Paper20028816
Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.
Zander J and 3 others. Antimicrob Agents Chemother, 2010. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs. Papers, record 20028816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028816
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Folic Acid Antagonists | Major topic |
| Gram-Negative Bacteria | Major topic |
| Gram-Positive Bacteria | Major topic |
| Nucleosides | Major topic |
| Trimethoprim, Sulfamethoxazole Drug Combination | Major topic |
| Drug Synergism | |
| Humans | |
| Idoxuridine | |
| Microbial Sensitivity Tests | |
| Nucleic Acid Synthesis Inhibitors | |
| Staphylococcus aureus | |
| Thymidine |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4611429 | The biochemical basis of the antimicrobial action of sulfonamides and trimethoprim in vivo--I. Action of sulfonamides and trimethoprim in blood and urine. | Biochem Pharmacol | 1974 | https://conductscience.org/library/papers/4611429 | PubMed |
| 3 | 18197761 | Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. | Clin Infect Dis | 2008 | https://conductscience.org/library/papers/18197761 | PubMed |
| 4 | 18160477 | Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus. | Infect Immun | 2008 | https://conductscience.org/library/papers/18160477 | PubMed |
| 5 | 3494425 | Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3494425 | PubMed |
| 6 | 3547456 | [Isolation of thymidine-dependent strains. Microbiologic considerations and personal observations]. | Quad Sclavo Diagn | 1986 | https://conductscience.org/library/papers/3547456 | PubMed |
| 7 | 5361314 | Species differences among dihydrofolate reductases as a basis for chemotherapy. | Postgrad Med J | 1969 | https://conductscience.org/library/papers/5361314 | PubMed |
| 8 | 16541137 | Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. | Nat Rev Microbiol | 2006 | https://conductscience.org/library/papers/16541137 | PubMed |
| 9 | 12485347 | Efficacy of trimethoprim-sulfadoxine against Escherichia coli in a tissue cage model in calves. | J Vet Pharmacol Ther | 2002 | https://conductscience.org/library/papers/12485347 | PubMed |
| 10 | 15678184 | The nucleoside transport proteins, NupC and NupG, from Escherichia coli: specific structural motifs necessary for the binding of ligands. | Org Biomol Chem | 2005 | https://conductscience.org/library/papers/15678184 | PubMed |
| 11 | 15935511 | Nucleotide metabolism and its control in lactic acid bacteria. | FEMS Microbiol Rev | 2005 | https://conductscience.org/library/papers/15935511 | PubMed |
| 12 | 15980375 | In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15980375 | PubMed |
| 13 | 7261250 | Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7261250 | PubMed |
| 14 | 1089874 | Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1089874 | PubMed |
| 15 | 7304970 | Radioimmunoassays of plasma thymidine, uridine, deoxyuridine, and cytidine/deoxycytidine. | Anal Biochem | 1981 | https://conductscience.org/library/papers/7304970 | PubMed |
| 16 | 16978420 | Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. | Ann Clin Microbiol Antimicrob | 2006 | https://conductscience.org/library/papers/16978420 | PubMed |
| 17 | 9145866 | Efficacy of trimethoprim in murine experimental infection with a thymidine kinase-deficient mutant of Escherichia coli. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145866 | PubMed |
| 18 | 18832128 | Thymidine-dependent Staphylococcus aureus small-colony variants: human pathogens that are relevant not only in cases of cystic fibrosis lung disease. | J Clin Microbiol | 2008 | https://conductscience.org/library/papers/18832128 | PubMed |
| 19 | 4608311 | Thymidine-dependent Escherichia coli infection and some associated laboratory problems. | J Clin Pathol | 1974 | https://conductscience.org/library/papers/4608311 | PubMed |
| 20 | 412502 | Thymidine concentrations in serum and urine of different animal species and man. | Biochem Pharmacol | 1977 | https://conductscience.org/library/papers/412502 | PubMed |
| 21 | 4400416 | Genetic and biochemical properties of thymidine-dependent mutants of pneumococcus. | J Bacteriol | 1972 | https://conductscience.org/library/papers/4400416 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41868124 | Pyrimidine nucleoside: inspiration for novel antimicrobial agent. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41868124 | PubMed |
| 39688409 | Repurposing zidovudine and 5-fluoro-2'-deoxyuridine as antibiotic drugs made possible by synergy with both trimethoprim and the mitochondrial toxicity-reducing agent uridine. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/39688409 | PubMed |
| 37894029 | Loss in the Antibacterial Ability of a PyrR Gene Regulating Pyrimidine Biosynthesis after Using CRISPR/Cas9-Mediated Knockout for Metabolic Engineering in Lactobacillus casei. | Microorganisms | 2023 | https://conductscience.org/library/papers/37894029 | PubMed |
| 32785422 | Prioritisation of potential drug targets against Bartonella bacilliformis by an integrative in-silico approach. | Mem Inst Oswaldo Cruz | 2020 | https://conductscience.org/library/papers/32785422 | PubMed |
| 31191461 | Nucleoside Analogues as Antibacterial Agents. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31191461 | PubMed |
| 28808156 | Identification of Staphylococcus aureus Factors Required for Pathogenicity and Growth in Human Blood. | Infect Immun | 2017 | https://conductscience.org/library/papers/28808156 | PubMed |
| 22276115 | Structure of S. aureus HPPK and the discovery of a new substrate site inhibitor. | PLoS One | 2012 | https://conductscience.org/library/papers/22276115 | PubMed |
| 21245845 | Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. | Mol Syst Biol | 2011 | https://conductscience.org/library/papers/21245845 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20028816
GET https://conductscience.org/api/papers/v1/20028816/references?page=2